Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: 2012-0618: A Randomized Phase II Study Assessing the Efficacy of Local Consolidative Therapy for Non-small Cell Lung Cancer patients with Induced Oligometastatic Disease

 


2012-0618: A Randomized Phase II Study Assessing the Efficacy of Local Consolidative Therapy for Non-small Cell Lung Cancer patients with Induced Oligometastatic Disease


Trial Focus

Lung Cancer

Objective

         This is a clinical trial of Local Consolidative Therapy (LCT) which will be administered after chemotherapy.

IRB Protocol #

13-2489

Trial Status

OPEN

Principle Investigator

BRIAN KAVANAGH

Sponsor

M. D. Anderson Cancer Center

Contact

MONICA ROBISCHON at (720) 848-0661 or MONICA.ROBISCHON@UCDENVER.EDU

Location

University of Colorado Hospital University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : A screening period will determine eligibility. You will have screening tests to help the doctor decide if you are eligible to take part in this study. This study will have 2 different groups of research subjects like you. You will be randomly assigned to 1 of the following 2 groups: Group 1 will receive LCT after induction chemotherapy. Group 2 will not receive LCT after induction chemotherapy. If the disease has gotten worse after 4-6 rounds of induction chemotherapy, you will no longer be eligible to participate in this study and the study doctor will talk to you about other options. // Eligibility criteria include but are not limited to 18 years or older with oligometastatic disease.Eligibility criteria include but are not limited to 18 years or older with oligometastatic disease.